Uterotonic use at home births in low-income countries: A literature review

Dawn Flandermeyer, Cynthia Stanton, Deborah Armbruster

Research output: Contribution to journalArticle

Abstract

Objectives: This literature review compiles data on rates of use, indications, types of provider, mode of administration, and dose of uterotonics used for home births in low-income countries, and identifies gaps meriting further research. Methods: Published and unpublished English language articles from 1995 through 2008 pertaining to home use of uterotonics were identified via electronic searches of medical and social science databases. In addition, bibliographies of articles were examined for eligible studies. Data were abstracted and analyzed by the objectives outlined for this review. Results: Twenty-three articles met the inclusion/exclusion criteria. Use rates of uterotonics at home births ranged widely from 1% to 69%, with the large majority of observations from South Asia. Descriptive studies suggest that home use of uterotonics before delivery of the baby are predominantly administered by nonprofessionals to accelerate labor, and are not perceived as unsafe. Conclusions: To achieve maximum benefit and minimal harm, programs that increase access to uterotonics for postpartum hemorrhage prevention must take into account existing practices among pregnant women. Further research regarding access to uterotonics and intervention studies for provider behavior change regarding uterotonic use is warranted.

Original languageEnglish (US)
Pages (from-to)269-275
Number of pages7
JournalInternational Journal of Gynecology and Obstetrics
Volume108
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Medical Electronics
Parturition
Postpartum Hemorrhage
Social Sciences
Bibliography
Research
Pregnant Women
Language
Databases

Keywords

  • Home birth
  • Labor augmentation
  • Misoprostol
  • Oxytocin
  • Postpartum hemorrhage
  • Uterotonics

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Uterotonic use at home births in low-income countries : A literature review. / Flandermeyer, Dawn; Stanton, Cynthia; Armbruster, Deborah.

In: International Journal of Gynecology and Obstetrics, Vol. 108, No. 3, 03.2010, p. 269-275.

Research output: Contribution to journalArticle

Flandermeyer, Dawn ; Stanton, Cynthia ; Armbruster, Deborah. / Uterotonic use at home births in low-income countries : A literature review. In: International Journal of Gynecology and Obstetrics. 2010 ; Vol. 108, No. 3. pp. 269-275.
@article{f359dbe9d65947a2966e44b3a0dc6fbc,
title = "Uterotonic use at home births in low-income countries: A literature review",
abstract = "Objectives: This literature review compiles data on rates of use, indications, types of provider, mode of administration, and dose of uterotonics used for home births in low-income countries, and identifies gaps meriting further research. Methods: Published and unpublished English language articles from 1995 through 2008 pertaining to home use of uterotonics were identified via electronic searches of medical and social science databases. In addition, bibliographies of articles were examined for eligible studies. Data were abstracted and analyzed by the objectives outlined for this review. Results: Twenty-three articles met the inclusion/exclusion criteria. Use rates of uterotonics at home births ranged widely from 1{\%} to 69{\%}, with the large majority of observations from South Asia. Descriptive studies suggest that home use of uterotonics before delivery of the baby are predominantly administered by nonprofessionals to accelerate labor, and are not perceived as unsafe. Conclusions: To achieve maximum benefit and minimal harm, programs that increase access to uterotonics for postpartum hemorrhage prevention must take into account existing practices among pregnant women. Further research regarding access to uterotonics and intervention studies for provider behavior change regarding uterotonic use is warranted.",
keywords = "Home birth, Labor augmentation, Misoprostol, Oxytocin, Postpartum hemorrhage, Uterotonics",
author = "Dawn Flandermeyer and Cynthia Stanton and Deborah Armbruster",
year = "2010",
month = "3",
doi = "10.1016/j.ijgo.2009.12.001",
language = "English (US)",
volume = "108",
pages = "269--275",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Uterotonic use at home births in low-income countries

T2 - A literature review

AU - Flandermeyer, Dawn

AU - Stanton, Cynthia

AU - Armbruster, Deborah

PY - 2010/3

Y1 - 2010/3

N2 - Objectives: This literature review compiles data on rates of use, indications, types of provider, mode of administration, and dose of uterotonics used for home births in low-income countries, and identifies gaps meriting further research. Methods: Published and unpublished English language articles from 1995 through 2008 pertaining to home use of uterotonics were identified via electronic searches of medical and social science databases. In addition, bibliographies of articles were examined for eligible studies. Data were abstracted and analyzed by the objectives outlined for this review. Results: Twenty-three articles met the inclusion/exclusion criteria. Use rates of uterotonics at home births ranged widely from 1% to 69%, with the large majority of observations from South Asia. Descriptive studies suggest that home use of uterotonics before delivery of the baby are predominantly administered by nonprofessionals to accelerate labor, and are not perceived as unsafe. Conclusions: To achieve maximum benefit and minimal harm, programs that increase access to uterotonics for postpartum hemorrhage prevention must take into account existing practices among pregnant women. Further research regarding access to uterotonics and intervention studies for provider behavior change regarding uterotonic use is warranted.

AB - Objectives: This literature review compiles data on rates of use, indications, types of provider, mode of administration, and dose of uterotonics used for home births in low-income countries, and identifies gaps meriting further research. Methods: Published and unpublished English language articles from 1995 through 2008 pertaining to home use of uterotonics were identified via electronic searches of medical and social science databases. In addition, bibliographies of articles were examined for eligible studies. Data were abstracted and analyzed by the objectives outlined for this review. Results: Twenty-three articles met the inclusion/exclusion criteria. Use rates of uterotonics at home births ranged widely from 1% to 69%, with the large majority of observations from South Asia. Descriptive studies suggest that home use of uterotonics before delivery of the baby are predominantly administered by nonprofessionals to accelerate labor, and are not perceived as unsafe. Conclusions: To achieve maximum benefit and minimal harm, programs that increase access to uterotonics for postpartum hemorrhage prevention must take into account existing practices among pregnant women. Further research regarding access to uterotonics and intervention studies for provider behavior change regarding uterotonic use is warranted.

KW - Home birth

KW - Labor augmentation

KW - Misoprostol

KW - Oxytocin

KW - Postpartum hemorrhage

KW - Uterotonics

UR - http://www.scopus.com/inward/record.url?scp=76049088527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76049088527&partnerID=8YFLogxK

U2 - 10.1016/j.ijgo.2009.12.001

DO - 10.1016/j.ijgo.2009.12.001

M3 - Article

C2 - 20053400

AN - SCOPUS:76049088527

VL - 108

SP - 269

EP - 275

JO - International Journal of Gynecology and Obstetrics

JF - International Journal of Gynecology and Obstetrics

SN - 0020-7292

IS - 3

ER -